ECMO et support cardio-circulatoire. [ECMO and cardiopulmonary support]

Details

Serval ID
serval:BIB_0B2B343632B1
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
ECMO et support cardio-circulatoire. [ECMO and cardiopulmonary support]
Journal
Revue Médicale de la Suisse Romande
Author(s)
Mueller  X. M., Tevaearai  H. T., Horisberger  J., Godar  G., von Segesser  L. K.
ISSN
0035-3655
Publication state
Published
Issued date
03/2002
Volume
122
Number
3
Pages
127-30
Notes
English Abstract
Journal Article
Review --- Old month value: Mar
Abstract
ECMO (extracorporeal membrane oxygenation) may be viewed as a prolonged cardiopulmonary bypass allowing for a prolonged cardio-respiratory support. Since its introduction in the 60's, its indication has expanded from acute respiratory failure to acute cardiac failure refractory to conventional treatments. The target group involves mainly those patients presenting with a cardiogenic shock following cardiac surgery or acute myocardial infarction. The advantages of this form of circulatory support, when compared with long-term ventricular assist devices, are its less invasive aspect, its ease of implantation and its reduced cost. However, its main limitation lies in its limited duration of 7 to 10 days, in particular because of hemorrhage complications. Currently, ECMO provides a temporary hemodynamical stability in order to perform an invasive cardiac treatment (coronary bypass or percutaneous dilatation), or to assess the eligibility of the patient for a long-term ventricular assist device, which will enable to wait for the availability of an allograft. The latter scenario is crucial nowadays because of the severe lack of organ donors, which is the leading cause of death among patients waiting for a heart transplant.
Keywords
Cardiac Output, Low/*therapy Extracorporeal Membrane Oxygenation/adverse effects/*methods Humans Shock, Cardiogenic/*therapy
Pubmed
Create date
14/02/2008 14:17
Last modification date
20/08/2019 12:32
Usage data